Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 10 of 55 descriptions
| No. | 薬物名（臨床試験情報から抽出） | DrugBank | KEGG DRUG | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | AZD4017 and prednisolone (D00472) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(D00472) 💬1. AZD4017 and prednisolone
| 1件: NR3C1 NR3C1 💬1. AZD4017 and prednisolone
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 75 75 💬1. AZD4017 and prednisolone
| ||||||||||||||||||||||||
| 2 | Combination therapy with vigabatrin and prednisolone (D00472) | 2件: Prednisolone Prednisolone,Vigabatrin | 2件: Prednisolone
Prednisolone
(D00472),Vigabatrin 💬 2. Combination therapy with vigabatrin and prednisolone
| 2件: ABAT ABAT,NR3C1 💬 | 8件: Alanine, aspartate and glutamate metabolism Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic pathways, Neuroactive ligand-receptor interaction, Propanoate metabolism, Valine, leucine and isoleucine degradation, beta-Alanine metabolism 💬 8件: Alanine, aspartate and glutamate metabolism, Butanoate metabolism, GABAergic synapse, Metabolic ... | 1件: 145 145 💬2. Combination therapy with vigabatrin and prednisolone
| ||||||||||||||||||||||||
| 3 | Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone) (D00472) Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, predn ... | 7件: Acetate Acetate,Cortisone, Cortisone acetate, Dexamethasone, Hydrocortisone, Prednisolone, Prednisone | 6件: Hydrocortisone
Hydrocortisone
,Dexamethasone , Prednisolone (D00472), Prednisone , Cortisone acetate , Cortisone 💬 6件: Hydrocortisone , Dexamethasone , Prednisolone (D00472), Prednisone , Cortisone acetate ... 3. Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone)
| 1件: NR3C1 NR3C1 💬3. Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone)
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 81 81 💬3. Conventional Glucocorticoids (immediate release hydrocortisone, cortisone acetate, prednisone, prednisolone, dexamethasone)
| ||||||||||||||||||||||||
| 4 | Corticosteroid treatment (Methylprednisolone or prednisolone) (D00472) | 2件: Methylprednisolone Methylprednisolone,Prednisolone | 2件: Methylprednisolone
Methylprednisolone
,Prednisolone (D00472) 💬 4. Corticosteroid treatment (Methylprednisolone or prednisolone)
| 1件: NR3C1 NR3C1 💬4. Corticosteroid treatment (Methylprednisolone or prednisolone)
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 64 64 💬4. Corticosteroid treatment (Methylprednisolone or prednisolone)
| ||||||||||||||||||||||||
| 5 | Corticosteroids (prednisone or prednisolone) (D00472) | 2件: Prednisolone Prednisolone,Prednisone | 2件: Prednisolone
Prednisolone
(D00472),Prednisone 💬 5. Corticosteroids (prednisone or prednisolone)
| 1件: NR3C1 NR3C1 💬5. Corticosteroids (prednisone or prednisolone)
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 49 49 💬5. Corticosteroids (prednisone or prednisolone)
| ||||||||||||||||||||||||
| 6 | Etanercept, Methotrexate, Prednisolone (D00472) | 3件: Etanercept Etanercept,Methotrexate, Prednisolone | 3件: Methotrexate
Methotrexate
,Prednisolone (D00472), Etanercept 💬 6. Etanercept, Methotrexate, Prednisolone
| 5件: DHFR DHFR,DHFR2, LTA, NR3C1, TNF 💬 | 72件: AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Alzheimer disease, Amoebiasis, Amyotrophic lateral sclerosis, Antifolate resistance, Antigen processing and presentation, Apoptosis, Asthma, Biosynthesis of cofactors, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Dilated cardiomyopathy, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, Fluid shear stress and atherosclerosis, Folate biosynthesis, Graft-versus-host disease, Hematopoietic cell lineage, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Hypertrophic cardiomyopathy, IL-17 signaling pathway, Inflammatory bowel disease, Influenza A, Insulin resistance, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, MAPK signaling pathway, Malaria, Metabolic pathways, NF-kappa B signaling pathway, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Neuroactive ligand-receptor interaction, Non-alcoholic fatty liver disease, One carbon pool by folate, Osteoclast differentiation, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Pertussis, Prion disease, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Salmonella infection, Shigellosis, Sphingolipid signaling pathway, Systemic lupus erythematosus, T cell receptor signaling pathway, TGF-beta signaling pathway, TNF signaling pathway, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Type II diabetes mellitus, Viral protein interaction with cytokine and cytokine receptor, Yersinia infection, mTOR signaling pathway 💬 72件: AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, African ... | 1件: 56 56 💬6. Etanercept, Methotrexate, Prednisolone
| ||||||||||||||||||||||||
| 7 | Glucocorticoid (prednisone or prednisolone) (D00472) | 2件: Prednisolone Prednisolone,Prednisone | 2件: Prednisolone
Prednisolone
(D00472),Prednisone 💬 7. Glucocorticoid (prednisone or prednisolone)
| 1件: NR3C1 NR3C1 💬7. Glucocorticoid (prednisone or prednisolone)
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 84 84 💬7. Glucocorticoid (prednisone or prednisolone)
| ||||||||||||||||||||||||
| 8 | Intravenous methyl prednisolone (D00472) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(D00472) 💬8. Intravenous methyl prednisolone
| 1件: NR3C1 NR3C1 💬8. Intravenous methyl prednisolone
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 43 43 💬8. Intravenous methyl prednisolone
| ||||||||||||||||||||||||
| 9 | Large dose of prednisolone plus intra-lesional of Triamcinolone Acetonide followed the systemic combination of mycophenolate mofetil (MMF), dapsone and low dose prednisolone in treatment of MMP (D00472) Large dose of prednisolone plus intra-lesional of Triamcinolone Acetonide followed the systemic comb ... | 5件: Dapsone Dapsone,Mycophenolate mofetil, Mycophenolic acid, Prednisolone, Triamcinolone | 5件: Triamcinolone
Triamcinolone
,Prednisolone (D00472), Dapsone , Mycophenolate mofetil , Mycophenolic acid 💬 5件: Triamcinolone , Prednisolone (D00472), Dapsone , Mycophenolate mofetil , Mycophenolic ... 9. Large dose of prednisolone plus intra-lesional of Triamcinolone Acetonide followed the systemic combination of mycophenolate mofetil (MMF), dapsone and low dose prednisolone in treatment of MMP
| 3件: IMPDH1 IMPDH1,IMPDH2, NR3C1 💬 9. Large dose of prednisolone plus intra-lesional of Triamcinolone Acetonide followed the systemic combination of mycophenolate mofetil (MMF), dapsone and low dose prednisolone in treatment of MMP | 5件: Drug metabolism - other enzymes Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nucleotide metabolism, Purine metabolism 💬 5件: Drug metabolism - other enzymes, Metabolic pathways, Neuroactive ligand-receptor interaction, Nu ... | 1件: 162 162 💬9. Large dose of prednisolone plus intra-lesional of Triamcinolone Acetonide followed the systemic combination of mycophenolate mofetil (MMF), dapsone and low dose prednisolone in treatment of MMP
| ||||||||||||||||||||||||
| 10 | Lodotra (delayed release prednisolone) (D00472) | 1件: Prednisolone Prednisolone | 1件: Prednisolone
Prednisolone
(D00472) 💬10. Lodotra (delayed release prednisolone)
| 1件: NR3C1 NR3C1 💬10. Lodotra (delayed release prednisolone)
| 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 1件: 41 41 💬10. Lodotra (delayed release prednisolone)
|